Aurobindo Pharma Inaugurates TheraNym - Pioneering India's Large-Scale Biologics Contract Manufacturing Facility

Aurobindo Pharma Limited today marked a significant milestone with the inauguration of TheraNym, one of India's largest dedicated biologics contract manufacturing organisations (CMO). Ahead of the ceremony, the Directors of Aurobindo Pharma and the senior leadership team of MSD called upon Hon'ble Chief Minister Shri Anumula Revanth Reddy, briefing him on the project and expressing their gratitude for the Government's steadfast support. The TheraNym Biologics facility was then inaugurated by Shri D. Sridhar Babu, Hon'ble Minister for IT, Industries & Commerce and Legislative Affairs of Telangana, and Shri Damodar Raja Narasimha, Minister for Science and Technology of Telangana - a gesture that reaffirms the Government's unwavering commitment to positioning Telangana as a global centre of excellence in pharmaceuticals and biotechnology.

TheraNym represents Aurobindo Pharma's bold and strategic foray into biologics contract manufacturing - a segment that is growing worldwide and is increasingly vital to meeting global demand for biologic therapies.

"TheraNym represents a defining moment in large-scale biologics manufacturing in India and a proud milestone for Aurobindo Pharma. Designed and built to the highest international standards, the facility is positioned to serve the supply chains of leading global pharmaceutical companies. We are privileged to welcome MSD as TheraNym's anchor customer - their confidence in our capabilities is both an honour and a mandate to deliver excellence. As the global biologics market continues its remarkable expansion, TheraNym stands ready to help bring biologic therapies to patients worldwide, reliably and more affordably than before." - Dr. Satakarni Makkapati, CEO Biologics and Director, Aurobindo Pharma Limited.

The facility is strategically located in Borapatla approximately 45 minutes from the Hyderabad's bustling Financial District and is equipped with 15 KL bioreactors, advanced downstream processing suites, aseptic fill-finish capabilities, and quality control laboratories. TheraNym has been designed with international regulatory expectations in mind. The facility is intended to support MSD supply chain, both domestic and export markets, subject to applicable approvals and customer requirements.

"This innovative partnership reflects a shared commitment to strengthening global access to critical biologic medicines. TheraNym adds meaningful capacity and capability to the MSD supply chain, helping enable compliant, and reliable supply of products to the patients who need them most." - Dr. Dave Maraldo, MSD Executive Vice President and President, MSD Manufacturing Division.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1440.30 as compared to the previous close of Rs. 1429.35. The total number of shares traded during the day was 39293 in over 5173 trades.

The stock hit an intraday high of Rs. 1457.90 and intraday low of 1420.80. The net turnover during the day was Rs. 56680972.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 Pharmaceuticals Inauguration TheraNym